• Info
  • Insider Ownership

Insider Trading & Ownership of Richard A. Kayne

Summary
The estimated net worth of Richard A. Kayne is at least $1,600,204 dollars as of 02 Nov 2023. Richard A. Kayne is the 10%+ Owner of Eiger BioPharmaceuticals, Inc. and owns shares of Eiger BioPharmaceuticals, Inc. stock worth about $1.6M.
Signature
/s/ Richard A. Kayne
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Richard A. Kayne and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Richard A. Kayne has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $1,600,204.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Eiger BioPharmaceuticals, Inc. ($1,600,204).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Richard A. Kayne

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
EIGR Eiger BioPharmaceuticals, Inc. 10%+ Owner $1,600,204 31 Oct 2023

Insider Transactions Reported by Richard A. Kayne:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored